Informação sobre produto
- 4-(4-Acetyl-phenoxy)-butyric acid
- Butanoic acid, 4-(4-acetylphenoxy)-
- 4-(4-Acetylphenoxy)butanoic acid
4-(4-acetylphenoxy)butanoic acid is a conjugate that has been engineered to bind to the tumour antigen CD20. It also binds specifically to monoclonal antibodies and has an increased half-life in vivo. 4-(4-acetylphenoxy)butanoic acid is active against solid tumours and is effective in conjugates with monoclonal antibodies. Inotuzumab ozogamicin, which is a specific antibody conjugate of 4-(4-acetylphenoxy)butanoic acid, was developed as a treatment for B cell non-Hodgkin's lymphoma and acute lymphoblastic leukaemia. This drug has shown promising results in preclinical studies demonstrating an increased survival rate in animal models. The sugar residues on the surface of the antigen CD20 may enhance the efficacy of this immunoconjugate by increasing binding affinity.
Propriedades químicas
Consulta técnica sobre: 3D-QCA62382 4-(4-acetylphenoxy)butanoic acid
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.